Infection with GB virus C and reduced mortality among HIV-infected patients. - Wikidata - awgldk - TriplyDB

Infection with GB virus C and reduced mortality among HIV-infected patients.

Infection with GB virus C and reduced mortality among HIV-infected patients.

http://www.wikidata.org/entity/Q34090499

about

Hepatitis G virus Limited durability of viral control following treated acute HIV infection Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1 The virome in host health and disease HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status An Ecological Framework of the Human Virome Provides Classification of Current Knowledge and Identifies Areas of Forthcoming Discovery Evidence for Within-Host Genetic Recombination among the Human Pegiviral Strains in HIV Infected Subjects Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses Effect of Primer Selection on Estimates of GB Virus C (GBV-C) Prevalence and Response to Antiretroviral Therapy for Optimal Testing for GBV-C Viremia Conserved Determinants for Membrane Association of Nonstructural Protein 5A from Hepatitis C Virus and Related Viruses GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy HIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected]GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV Infection Modifications in SENV DNA detection and/or SENV subtype determination over a prospective follow-up in a cohort of HIV-positive patients: is this a moving target?A copula model for bivariate hybrid censored survival data with application to the MACS study Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro Discovery and characterization of distinct simian pegiviruses in three wild African Old World monkey species.Imputation methods for doubly censored HIV data.Holobiont-Holobiont interactions: redefining host-parasite interactions.Prevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, Brazil The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4+ T lymphocyte cell line without decreasing HIV receptor expression Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.GBV-C: state of the art and future prospects.The natural history of HIV infection.GB virus C infection and quality of life in HIV-positive patients.Recombinant interferon-γ lentivirus co-infection inhibits adenovirus replication ex vivo Intra-host diversity and emergence of unique GBV-C viral lineages in HIV infected subjects in central China.Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis.GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals The natural history of non-human GB virus C in captive chimpanzees.Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.Evaluation of prevalence and risk factors of hepatitis g virus infection among hemodialysis patients referred to Iranian army hospitals in tehran during 2012-2013.GB virus C coinfections in west African Ebola patients.Sequencing and Phylogenetic Study of Partial NS3 Gene of Iranian GB Virus C/Hepatitis G Virus (HGV) Originated From Hemodialysis Patients in Tehran.Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27.HIV and HCV coinfection in haemophilia.Differential clinical outcome of dengue infection among patients with and without HIV infection: a matched case-control study.Control of HIV-1 infection by soluble factors of the immune response.Downregulation of Cytokines and Chemokines by GB Virus C After Transmission Via Blood Transfusion in HIV-Positive Blood Recipients Emerging, re-emerging and submerging infectious threats to the blood supply.

P2860

Q24658258-FACF8ACE-21C8-4110-8752-B64D45C01CE0 Q24804986-A0BA9CF5-9E74-421D-9116-72A074BC2E9F Q24811407-5A81698E-5374-424B-8477-575F93FCBEFD Q26824795-35099E1C-8F48-4525-B1A9-84370D36B9DA Q26866444-E812DD8F-236D-4BD9-8ACB-EB3FEB606D80 Q27468626-C09D3246-7965-480D-8564-B389D02AF5EC Q27468827-13611B3B-00BC-462B-A672-CD79E2E52316 Q27472844-2884A003-AA83-4287-B93D-E6E7140F2E03 Q27477504-90FC49DA-2917-4FB4-87C8-632A34B820D6 Q27478371-03CF3185-A205-45BC-A489-CBD088D18610 Q27489561-CDD93484-C3E8-4376-90CA-2197D1C6DC3C Q28485218-8FEBFAA1-7868-4880-9DD6-6E7E639EA619 Q28542648-542033B7-F97B-4EA7-A42F-6EFFFA5C8FDB Q30977187-829E7D23-68D9-45DE-A1E3-0A6E541FC7E5 Q33516132-E5932436-170A-49E0-B618-668E9DEC6C1B Q33635101-010C57A5-2E38-49C1-8A4A-6C78EC9F57BF Q33740204-1B8EFF16-ACBA-4E95-8329-892ED3E1B0D9 Q33815357-2533522A-F2A1-4FC7-AA69-FC107E0BEEA2 Q33846136-1FB679CA-A3C0-4B97-BE44-39BFDFF35EB2 Q33869199-8F8B8310-C442-46BF-8D8D-1D315B18A26D Q34146275-707B45C2-5E95-4ADE-87D4-FBD788906A0D Q34159981-77F873E9-1461-432F-8F98-1B629A0551E9 Q34247167-0385E125-1F07-40F0-8F92-1ABE4D18E13D Q34337675-67216BF2-E0B8-47CC-941E-CD1DA1AC2BCE Q34348617-6A64D17C-211F-46E3-8F01-0EE421B05BD7 Q34390854-F301BC7E-A4B7-4023-95F5-0E447ABC8691 Q34477333-5E14A229-3830-46AC-B0B8-B3BAD9C62EC0 Q34496833-34A8F785-E3B1-489E-B906-DD65A39BDDB0 Q34500494-9043D67A-8C06-4B14-BF16-01A8E38A86AD Q34641703-63AC2DAD-517C-4560-BA16-6A79D41FEF62 Q35077776-68A08899-5C6E-4E3C-8050-96767DD7CCD0 Q35089905-D529FBC9-95B0-405B-8CC2-DCC68056650D Q35115707-B55DFCE7-A0A9-468B-B903-C6C0A6667220 Q35232622-1B8A0E8B-A76D-47B6-B769-8C109E7FED40 Q35642774-690852AB-7259-49E2-A14A-6968AC8FEE5B Q35666754-F3EBD7AA-6385-49F4-8C05-07288243DA2F Q35692491-0E8DED52-761B-4E67-B929-9AD188386BF6 Q35752416-14273A32-C515-42F4-B4D3-FDF95B302D06 Q35784618-4B140550-3096-4272-81B1-FBD8F0558B5C Q35812939-F5F61A8A-B8E1-4524-88D1-A969753F86DA

P2860

Infection with GB virus C and reduced mortality among HIV-infected patients.

http://www.wikidata.org/entity/Q34090499

description

2001 nî lūn-bûn

@nan

2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Infection with GB virus C and reduced mortality among HIV-infected patients.

@ast

Infection with GB virus C and reduced mortality among HIV-infected patients.

@en

Infection with GB virus C and reduced mortality among HIV-infected patients.

@nl

type

label

Infection with GB virus C and reduced mortality among HIV-infected patients.

@ast

Infection with GB virus C and reduced mortality among HIV-infected patients.

@en

Infection with GB virus C and reduced mortality among HIV-infected patients.

@nl

prefLabel

Infection with GB virus C and reduced mortality among HIV-infected patients.

@ast

Infection with GB virus C and reduced mortality among HIV-infected patients.

@en

Infection with GB virus C and reduced mortality among HIV-infected patients.

@nl

P1433

Q34090499-ADC843AB-ABEB-448D-B63E-3F094DE86A3B

P1476

Q34090499-0C39034C-30F6-4982-B790-8F0F2FBCA300

P2093

Q34090499-19AF6214-A2D5-44B2-8842-CBED0E9D1BE0

Q34090499-3FE65D6C-7BCF-4C12-BA7B-E6432815F13D

Q34090499-606B0573-F883-4D7C-8859-1406000B14CF

Q34090499-6A16D70B-E573-4022-B0FC-8383DA73341A

Q34090499-8340A460-AD8E-4D62-99E5-279F06F59EAE

Q34090499-9F875D6B-43C9-418C-B8C4-9D687037D0D9

Q34090499-A2377EB3-F1BA-42F5-AA4C-CB6FB6BD9806

Q34090499-A49CF3DB-0DA5-4DD9-91F9-D2DEC1D6DD97

Q34090499-A70C8A6B-4D54-4C4D-B6F5-A94C50E618D9

Q34090499-ADA25EEC-AE33-428F-BBFA-D3CA34C06BF8

P304

Q34090499-E9EEFD5F-C7EC-45ED-B555-A2214D6C56E2

P31

Q34090499-397EC1CD-DC73-467A-9CE3-3AC564DA5B6E

P356

Q34090499-48F1E3D7-F79F-42E5-B5E3-D6BC042E6B63

P407

Q34090499-21FA517A-50E0-40D2-A831-110C641C10D0

P433

Q34090499-0830CF6C-36D9-4992-BC70-EDBF2AE3A6FA

P478

Q34090499-C001011C-5CAD-455A-B9A4-695C04C93563

P577

Q34090499-F415D5BF-418E-4743-9EC2-7BCEFE1D4956

P698

Q34090499-A46EA858-3C11-48E3-BCCC-A83C828E325B

P921

Q34090499-AD782F9C-5968-499A-A355-B4C454003957

P356

P1433

The New England Journal of Medicine

P1476

Infection with GB virus C and reduced mortality among HIV-infected patients.

@en

P2093

Detmer J

http://www.w3.org/2001/XMLSchema#string

Goergen B

http://www.w3.org/2001/XMLSchema#string

Heiken H

http://www.w3.org/2001/XMLSchema#string

Heringlake S

http://www.w3.org/2001/XMLSchema#string

Knapik-Botor A

http://www.w3.org/2001/XMLSchema#string

Manns MP

http://www.w3.org/2001/XMLSchema#string

McMorrow M

http://www.w3.org/2001/XMLSchema#string

Ockenga J

http://www.w3.org/2001/XMLSchema#string

Schmidt RE

http://www.w3.org/2001/XMLSchema#string

Stoll M

http://www.w3.org/2001/XMLSchema#string

P304

715-724

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA010398

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

345

http://www.w3.org/2001/XMLSchema#string

P577

2001-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11547740

http://www.w3.org/2001/XMLSchema#string

P921